Novel o-Toluidine Metabolite in Rat Urine Associated with Urinary Bladder Carcinogenesis
Novel o-Toluidine Metabolite in Rat Urine Associated with Urinary Bladder Carcinogenesis
复制标题
大鼠尿液中新型邻甲苯胺代谢物与膀胱癌发生相关
DOI:
10.1021/acs.chemrestox.0c00098
复制
发表时间:
2020
影响因子:
4.1
通讯作者:
Miyoshi Noriyuki
中科院分区:
文献类型:
--
作者:
Tajima Yuya;Toyoda Takeshi;Hirayama Yuichiro;Matsushita Kohei;Yamada Takanori;Ogawa Kumiko;Watanabe Kenji;Takamura-Enya Takeji;Totsuka Yukari;Wakabayashi Keiji;Miyoshi Noriyuki
o-Toluidine (o-Tol), a monocyclic aromatic amine, causes bladder cancer in humans and experimental animals and is therefore classified as a Group 1 carcinogen (IARC) in which the carcinogenicity ofo-Tol is involved in metabolic activation, DNA damage, and DNA adduct formation. In the DNA adduct formation mechanism,o-Tol is metabolized byN-hydroxylation,N-acetoxylation, and then deacetoxylation to produce an electrophilic nitrenium ion, which is able to bind to a DNA base, such as dG-C8. Therefore, dG-C8-o-Tol is thought to be a plausible DNA adduct ofo-Tol exposure. However, direct detection of dG-C8-o-Tol in biological samples has not been reported yet. Here, we show that a novelo-Tol metabolite, 2-methyl-N1-(2-methylphenyl)benzene-1,4-diamine (MMBD), a dimer by head-to-tail binding, was identified for the first time ino-Tol-exposed rat urine. MMBD was also detected in a reaction ofo-Tol and S9 mix, indicating the formation was catalyzed by an enzymatic reaction. Moreover, MMBD showed a potent stronger mutagenicity inN-acetyltransferase overexpressedSalmonella typhimuriumstrains,and cytotoxicity in human bladder carcinoma T24 cells and human spleen lymphoblastoid TK6 cells compared witho-Tol. Furthermore, a DNA adduct (m/z478.1) corresponding to dG-MMBD was detected in the reaction of calf thymus DNA with rat urine containing MMBD, and also in hepatic DNA of rats treated witho-Tol. These results therefore suggested thato-Tol-induced bladder carcinogenesis could be at least partly attributed to MMBD formation. The possible dimerization of monocyclic aromatic amines should be considered in the evaluation of the risk of bladder carcinogenesis after exposure.